| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 ATM CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 8.33e-08 | 363 | 90 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CCND3 MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 ATM CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 9.97e-08 | 446 | 90 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | CCND3 MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 ATM CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 2.82e-06 | 600 | 90 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CCND3 MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 ATM CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 1.69e-05 | 709 | 90 | 13 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CCND3 MOK CSNK1D CSNK1E OASL CHEK2 PRKCD ROCK1 ATM GMPPB CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 1.81e-05 | 938 | 90 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | single-stranded DNA endodeoxyribonuclease activity | 2.45e-05 | 13 | 90 | 3 | GO:0000014 | |
| GeneOntologyMolecularFunction | kinase activity | CCND3 MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 ATM CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 3.69e-05 | 764 | 90 | 13 | GO:0016301 |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 1.20e-04 | 4 | 90 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 MRE11 MDN1 MYO1H ATAD2B RAD54L2 ABCC2 DHX29 KIF24 RAD50 | 4.41e-04 | 614 | 90 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | protein kinase binding | CCND3 PTPN11 KCNH1 CHEK2 DNM3 TNS2 PRKCD RAD54L2 GOLGA8O MAP4K2 GOLGA8N MAP3K2 | 5.37e-04 | 873 | 90 | 12 | GO:0019901 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DHX36 MRE11 RBBP8 PCIF1 MARF1 RAD54L2 DHX29 CDKAL1 DNMT1 RAD50 | 6.46e-04 | 645 | 90 | 10 | GO:0140640 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 7.09e-04 | 9 | 90 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 7.09e-04 | 9 | 90 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | helicase activity | 7.45e-04 | 158 | 90 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity | 1.03e-03 | 44 | 90 | 3 | GO:0004520 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.20e-03 | 262 | 90 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | kinase binding | CCND3 PTPN11 KCNH1 CHEK2 DNM3 TNS2 PRKCD RAD54L2 GOLGA8O MAP4K2 GOLGA8N MAP3K2 | 1.33e-03 | 969 | 90 | 12 | GO:0019900 |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 1.76e-03 | 14 | 90 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 2.03e-03 | 15 | 90 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | translation activator activity | 2.03e-03 | 15 | 90 | 2 | GO:0008494 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.61e-03 | 17 | 90 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.62e-03 | 127 | 90 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.76e-03 | 62 | 90 | 3 | GO:0003678 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 3.16e-03 | 65 | 90 | 3 | GO:0016706 | |
| GeneOntologyMolecularFunction | DNA nuclease activity | 3.44e-03 | 67 | 90 | 3 | GO:0004536 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.78e-03 | 441 | 90 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.79e-03 | 229 | 90 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.85e-03 | 562 | 90 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 3.99e-03 | 21 | 90 | 2 | GO:0061676 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 4.38e-03 | 22 | 90 | 2 | GO:0050321 | |
| GeneOntologyBiologicalProcess | DNA double-strand break processing | 2.23e-06 | 22 | 89 | 4 | GO:0000729 | |
| GeneOntologyBiologicalProcess | mitotic G2/M transition checkpoint | 5.56e-06 | 59 | 89 | 5 | GO:0044818 | |
| GeneOntologyBiologicalProcess | DNA strand resection involved in replication fork processing | 9.12e-06 | 10 | 89 | 3 | GO:0110025 | |
| GeneOntologyBiologicalProcess | negative regulation of G2/M transition of mitotic cell cycle | 1.82e-05 | 75 | 89 | 5 | GO:0010972 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle G2/M phase transition | 2.07e-05 | 77 | 89 | 5 | GO:1902750 | |
| GeneOntologyBiologicalProcess | organelle assembly | SNF8 RPL10L SNX4 MDN1 CSNK1D KIAA0586 CHEK2 OGFOD1 CFAP74 ATM GOLGA8O DHX29 KIF24 PLK4 RPL10 GOLGA8N | 2.59e-05 | 1138 | 89 | 16 | GO:0070925 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | RPL10L MDN1 CSNK1D CHEK2 OGFOD1 GOLGA8O DHX29 PLK4 RPL10 GOLGA8N | 3.82e-05 | 475 | 89 | 10 | GO:0140694 |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | CCND3 SNF8 RASSF5 DHX36 MRE11 PTPN11 CSNK1D CSNK1E PCIF1 CHEK2 PRKCD CTIF GOLGA8O DHX29 MAP4K2 GOLGA8N WDR24 RAD50 | 4.26e-05 | 1458 | 89 | 18 | GO:0051247 |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 4.30e-05 | 217 | 89 | 7 | GO:0000075 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 5.09e-05 | 152 | 89 | 6 | GO:0000086 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | CCND3 SNF8 RASSF5 YEATS2 MRE11 PTPN11 CSNK1D UCHL1 CHEK2 PRKCD ROCK1 ZZEF1 GOLGA8O ADAR MAP4K2 GOLGA8N WDR24 RAD50 | 5.56e-05 | 1488 | 89 | 18 | GO:0031399 |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 7.51e-05 | 163 | 89 | 6 | GO:0007093 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 8.11e-05 | 240 | 89 | 7 | GO:0140013 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 9.61e-05 | 106 | 89 | 5 | GO:0032091 | |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 9.78e-05 | 171 | 89 | 6 | GO:0044839 | |
| GeneOntologyBiologicalProcess | DNA repair | MRE11 TICRR TADA1 SLF2 RBBP8 CSNK1E CHEK2 MARF1 ATM JMY RAD50 | 1.07e-04 | 648 | 89 | 11 | GO:0006281 |
| GeneOntologyBiologicalProcess | telomeric 3' overhang formation | 1.10e-04 | 4 | 89 | 2 | GO:0031860 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 1.25e-04 | 112 | 89 | 5 | GO:0032204 | |
| GeneOntologyBiologicalProcess | cell cycle process | CCND3 RPL10L MRE11 TICRR PTPN11 SLC16A1 SLF2 RBBP8 CSNK1D CHEK2 MARF1 ROCK1 ATM GOLGA8O PLK4 GOLGA8N RAD50 | 1.26e-04 | 1441 | 89 | 17 | GO:0022402 |
| GeneOntologyBiologicalProcess | positive regulation of chromosome organization | 1.30e-04 | 113 | 89 | 5 | GO:2001252 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 1.36e-04 | 350 | 89 | 8 | GO:0051321 | |
| GeneOntologyBiologicalProcess | regulation of G2/M transition of mitotic cell cycle | 1.47e-04 | 116 | 89 | 5 | GO:0010389 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 1.61e-04 | 268 | 89 | 7 | GO:1903046 | |
| GeneOntologyBiologicalProcess | organelle localization | SNF8 SNX4 MDN1 CSNK1D UCHL1 DNM3 ATM GOLGA8O CLUH MAP4K2 GOLGA8N | 2.17e-04 | 703 | 89 | 11 | GO:0051640 |
| GeneOntologyBiologicalProcess | DNA damage response | MRE11 TICRR PTPN11 TADA1 SLF2 RBBP8 CSNK1E CHEK2 MARF1 PRKCD ATM JMY RAD50 | 2.32e-04 | 959 | 89 | 13 | GO:0006974 |
| GeneOntologyBiologicalProcess | ribosomal large subunit assembly | 2.35e-04 | 28 | 89 | 3 | GO:0000027 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 2.59e-04 | 131 | 89 | 5 | GO:1902749 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance | 2.66e-04 | 72 | 89 | 4 | GO:0032206 | |
| GeneOntologyBiologicalProcess | ribosome assembly | 2.96e-04 | 74 | 89 | 4 | GO:0042255 | |
| GeneOntologyBiologicalProcess | homologous recombination | 2.96e-04 | 74 | 89 | 4 | GO:0035825 | |
| GeneOntologyBiologicalProcess | DNA damage checkpoint signaling | 3.08e-04 | 136 | 89 | 5 | GO:0000077 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 3.73e-04 | 219 | 89 | 6 | GO:1901991 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 3.97e-04 | 311 | 89 | 7 | GO:1901988 | |
| GeneOntologyBiologicalProcess | DNA integrity checkpoint signaling | 4.14e-04 | 145 | 89 | 5 | GO:0031570 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 5.07e-04 | 324 | 89 | 7 | GO:0006302 | |
| GeneOntologyBiologicalProcess | regulation of mitotic recombination | 5.07e-04 | 8 | 89 | 2 | GO:0000019 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 6.24e-04 | 90 | 89 | 4 | GO:0010833 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere capping | 6.50e-04 | 9 | 89 | 2 | GO:1904354 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 6.50e-04 | 9 | 89 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | R-loop processing | 6.50e-04 | 9 | 89 | 2 | GO:0062176 | |
| GeneOntologyBiologicalProcess | mitotic DNA damage checkpoint signaling | 6.50e-04 | 91 | 89 | 4 | GO:0044773 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 6.60e-04 | 244 | 89 | 6 | GO:0022618 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | CCND3 RASSF5 MRE11 PTPN11 CSNK1D CHEK2 PRKCD GOLGA8O MAP4K2 GOLGA8N WDR24 RAD50 | 6.81e-04 | 937 | 89 | 12 | GO:0031401 |
| GeneOntologyBiologicalProcess | mitotic G2 DNA damage checkpoint signaling | 6.84e-04 | 40 | 89 | 3 | GO:0007095 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | DHX36 MRE11 TICRR TADA1 SLF2 RBBP8 CSNK1E CHEK2 MARF1 PRKCD ATM JMY RAD50 | 7.23e-04 | 1081 | 89 | 13 | GO:0006259 |
| GeneOntologyBiologicalProcess | telomere capping | 7.35e-04 | 41 | 89 | 3 | GO:0016233 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | CCND3 SNF8 MRE11 PTPN11 CSNK1D UCHL1 CHEK2 PRKCD ROCK1 ZZEF1 ADAR MAP4K2 WDR24 RAD50 | 7.40e-04 | 1226 | 89 | 14 | GO:0042325 |
| GeneOntologyBiologicalProcess | mitotic DNA integrity checkpoint signaling | 7.64e-04 | 95 | 89 | 4 | GO:0044774 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 8.08e-04 | 168 | 89 | 5 | GO:0000723 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 8.14e-04 | 254 | 89 | 6 | GO:0071826 | |
| GeneOntologyBiologicalProcess | negative regulation of binding | 8.52e-04 | 170 | 89 | 5 | GO:0051100 | |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | 8.73e-04 | 701 | 89 | 10 | GO:0009896 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | SNF8 DHX36 CRTC3 SNX4 CSNK1D CSNK1E UCHL1 CHEK2 PRKCD ROCK1 ATM GOLGA8O GOLGA8N WDR24 | 9.07e-04 | 1252 | 89 | 14 | GO:0009894 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | PTPN11 SLF2 CSNK1D CSNK1E ZNF451 CHEK2 OGFOD1 PRKCD ROCK1 ATM ZZEF1 CDC42BPB | 9.72e-04 | 976 | 89 | 12 | GO:0018193 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 9.72e-04 | 362 | 89 | 7 | GO:0010948 | |
| GeneOntologyBiologicalProcess | oxaloacetate metabolic process | 9.87e-04 | 11 | 89 | 2 | GO:0006107 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | CCND3 SNF8 MRE11 PTPN11 CSNK1D UCHL1 CHEK2 PRKCD ZZEF1 ADAR MAP4K2 WDR24 RAD50 | 1.11e-03 | 1133 | 89 | 13 | GO:0001932 |
| GeneOntologyBiologicalProcess | mannose metabolic process | 1.18e-03 | 12 | 89 | 2 | GO:0006013 | |
| GeneOntologyBiologicalProcess | regulation of autophagosome assembly | 1.31e-03 | 50 | 89 | 3 | GO:2000785 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 1.33e-03 | 188 | 89 | 5 | GO:0000724 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | CCND3 MRE11 PTPN11 CSNK1D UCHL1 CHEK2 PRKCD ROCK1 MAP4K2 WDR24 RAD50 | 1.39e-03 | 879 | 89 | 11 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | CCND3 MRE11 PTPN11 CSNK1D UCHL1 CHEK2 PRKCD ROCK1 MAP4K2 WDR24 RAD50 | 1.39e-03 | 879 | 89 | 11 | GO:0010562 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 1.39e-03 | 282 | 89 | 6 | GO:0045930 | |
| GeneOntologyCellularComponent | BRCA1-C complex | 1.48e-06 | 6 | 89 | 3 | GO:0070533 | |
| GeneOntologyCellularComponent | site of double-strand break | 7.17e-05 | 101 | 89 | 5 | GO:0035861 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 1.07e-04 | 176 | 89 | 6 | GO:0000781 | |
| GeneOntologyCellularComponent | Mre11 complex | 1.78e-04 | 5 | 89 | 2 | GO:0030870 | |
| GeneOntologyCellularComponent | site of DNA damage | 3.00e-04 | 137 | 89 | 5 | GO:0090734 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 3.71e-04 | 33 | 89 | 3 | GO:0000137 | |
| Domain | ZF_DAG_PE_1 | 5.18e-07 | 64 | 87 | 6 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.18e-07 | 64 | 87 | 6 | PS50081 | |
| Domain | C1 | 5.68e-07 | 65 | 87 | 6 | SM00109 | |
| Domain | PE/DAG-bd | 6.23e-07 | 66 | 87 | 6 | IPR002219 | |
| Domain | PROTEIN_KINASE_ST | MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 9.36e-07 | 362 | 87 | 11 | PS00108 |
| Domain | Kinase-like_dom | MOK CSNK1D CSNK1E CHEK2 DNM3 PRKCD ROCK1 ATM CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 1.29e-06 | 542 | 87 | 13 | IPR011009 |
| Domain | Pkinase | MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 1.54e-06 | 381 | 87 | 11 | PF00069 |
| Domain | Ser/Thr_kinase_AS | MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 CDC42BPB MAP4K2 MAP3K2 MAP3K19 | 6.22e-06 | 357 | 87 | 10 | IPR008271 |
| Domain | S_TKc | MOK CSNK1D CHEK2 PRKCD ROCK1 CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 6.53e-06 | 359 | 87 | 10 | SM00220 |
| Domain | PROTEIN_KINASE_ATP | MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 9.14e-06 | 459 | 87 | 11 | PS00107 |
| Domain | Protein_kinase_ATP_BS | MOK CSNK1D CSNK1E PRKCD ROCK1 CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 1.05e-05 | 379 | 87 | 10 | IPR017441 |
| Domain | Prot_kinase_dom | MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 1.65e-05 | 489 | 87 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MOK CSNK1D CSNK1E CHEK2 PRKCD ROCK1 CDC42BPB PLK4 MAP4K2 MAP3K2 MAP3K19 | 1.78e-05 | 493 | 87 | 11 | PS50011 |
| Domain | Ribosomal_L10e_CS | 2.14e-05 | 2 | 87 | 2 | IPR018255 | |
| Domain | Ribosomal_L10e | 2.14e-05 | 2 | 87 | 2 | IPR001197 | |
| Domain | RIBOSOMAL_L10E | 2.14e-05 | 2 | 87 | 2 | PS01257 | |
| Domain | Ribosomal_L10e/L16 | 6.42e-05 | 3 | 87 | 2 | IPR016180 | |
| Domain | - | 6.42e-05 | 3 | 87 | 2 | 3.90.1170.10 | |
| Domain | Ribosomal_L16 | 6.42e-05 | 3 | 87 | 2 | PF00252 | |
| Domain | C1_1 | 1.44e-04 | 57 | 87 | 4 | PF00130 | |
| Domain | Cupin_4 | 4.44e-04 | 7 | 87 | 2 | PF08007 | |
| Domain | - | 4.75e-04 | 391 | 87 | 8 | 2.30.29.30 | |
| Domain | GPCR_3_mtglu_rcpt | 5.90e-04 | 8 | 87 | 2 | IPR000162 | |
| Domain | Pkinase_C | 6.76e-04 | 37 | 87 | 3 | IPR017892 | |
| Domain | PH_dom-like | 8.32e-04 | 426 | 87 | 8 | IPR011993 | |
| Domain | MIF4G | 9.42e-04 | 10 | 87 | 2 | SM00543 | |
| Domain | MIF4G | 9.42e-04 | 10 | 87 | 2 | PF02854 | |
| Domain | MIF4G-like_typ-3 | 9.42e-04 | 10 | 87 | 2 | IPR003890 | |
| Domain | Pkinase_C | 9.83e-04 | 42 | 87 | 3 | PF00433 | |
| Domain | NCD3G | 1.62e-03 | 13 | 87 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.62e-03 | 13 | 87 | 2 | IPR011500 | |
| Domain | GPCR_3_CS | 1.88e-03 | 14 | 87 | 2 | IPR017979 | |
| Domain | CNH | 1.88e-03 | 14 | 87 | 2 | SM00036 | |
| Domain | PH | 1.90e-03 | 278 | 87 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 1.93e-03 | 279 | 87 | 6 | PS50003 | |
| Domain | PH_domain | 1.97e-03 | 280 | 87 | 6 | IPR001849 | |
| Domain | CNH | 2.17e-03 | 15 | 87 | 2 | PF00780 | |
| Domain | MIF4-like | 2.17e-03 | 15 | 87 | 2 | IPR016021 | |
| Domain | CNH | 2.17e-03 | 15 | 87 | 2 | PS50219 | |
| Domain | CNH_dom | 2.17e-03 | 15 | 87 | 2 | IPR001180 | |
| Domain | - | 2.17e-03 | 15 | 87 | 2 | 1.25.40.180 | |
| Domain | AGC-kinase_C | 2.26e-03 | 56 | 87 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.26e-03 | 56 | 87 | 3 | PS51285 | |
| Domain | S_TK_X | 2.26e-03 | 56 | 87 | 3 | SM00133 | |
| Domain | DUF1605 | 2.79e-03 | 17 | 87 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 2.79e-03 | 17 | 87 | 2 | PF07717 | |
| Domain | GOLGA2L5 | 3.13e-03 | 18 | 87 | 2 | PF15070 | |
| Domain | Golgin_A | 3.13e-03 | 18 | 87 | 2 | IPR024858 | |
| Domain | HA2 | 3.13e-03 | 18 | 87 | 2 | SM00847 | |
| Domain | HA2 | 3.13e-03 | 18 | 87 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 3.13e-03 | 18 | 87 | 2 | IPR007502 | |
| Domain | GPCR_3 | 4.25e-03 | 21 | 87 | 2 | IPR000337 | |
| Domain | DAG/PE-bd | 4.25e-03 | 21 | 87 | 2 | IPR020454 | |
| Domain | PH | 4.34e-03 | 229 | 87 | 5 | PF00169 | |
| Pathway | BIOCARTA_ATM_PATHWAY | 3.30e-08 | 20 | 68 | 5 | M10628 | |
| Pathway | PID_ATM_PATHWAY | 5.62e-07 | 34 | 68 | 5 | M84 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 2.12e-06 | 6 | 68 | 3 | M27585 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 2.12e-06 | 6 | 68 | 3 | MM15295 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 2.95e-06 | 47 | 68 | 5 | M39518 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 3.39e-06 | 22 | 68 | 4 | M9703 | |
| Pathway | WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR | 3.71e-06 | 7 | 68 | 3 | M39689 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 6.83e-06 | 26 | 68 | 4 | MM15297 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 7.99e-06 | 27 | 68 | 4 | M27586 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 9.20e-06 | 59 | 68 | 5 | M261 | |
| Pathway | PID_BARD1_PATHWAY | 1.07e-05 | 29 | 68 | 4 | M258 | |
| Pathway | WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.72e-05 | 11 | 68 | 3 | M42562 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE | 1.99e-05 | 69 | 68 | 5 | M39339 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 2.29e-05 | 12 | 68 | 3 | M27569 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 2.29e-05 | 12 | 68 | 3 | MM15282 | |
| Pathway | WP_HOMOLOGOUS_RECOMBINATION | 2.29e-05 | 12 | 68 | 3 | MM15951 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 2.32e-05 | 35 | 68 | 4 | MM15293 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 2.45e-05 | 72 | 68 | 5 | MM15381 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 2.60e-05 | 36 | 68 | 4 | MM15281 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 2.90e-05 | 37 | 68 | 4 | M27583 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 2.90e-05 | 37 | 68 | 4 | M27568 | |
| Pathway | WP_HOMOLOGOUS_RECOMBINATION | 2.97e-05 | 13 | 68 | 3 | M39712 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING | 2.97e-05 | 13 | 68 | 3 | M47832 | |
| Pathway | WP_ATM_SIGNALING | 3.97e-05 | 40 | 68 | 4 | M39433 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 4.34e-05 | 81 | 68 | 5 | M39490 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 5.30e-05 | 43 | 68 | 4 | M27588 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 8.00e-05 | 92 | 68 | 5 | MM15338 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 8.00e-05 | 92 | 68 | 5 | M27636 | |
| Pathway | WP_INTEGRATED_CANCER_PATHWAY | 8.21e-05 | 48 | 68 | 4 | M39628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING | 8.32e-05 | 18 | 68 | 3 | M47838 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 8.32e-05 | 18 | 68 | 3 | MM15342 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 8.86e-05 | 94 | 68 | 5 | M1080 | |
| Pathway | BIOCARTA_ATM_PATHWAY | 9.84e-05 | 19 | 68 | 3 | MM1351 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 9.84e-05 | 19 | 68 | 3 | MM1478 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 9.84e-05 | 19 | 68 | 3 | M27639 | |
| Pathway | REACTOME_DISEASES_OF_DNA_REPAIR | 1.04e-04 | 51 | 68 | 4 | M29854 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.07e-04 | 157 | 68 | 6 | MM15226 | |
| Pathway | WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE | 1.08e-04 | 98 | 68 | 5 | M39524 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.19e-04 | 160 | 68 | 6 | M27498 | |
| Pathway | REACTOME_CELL_CYCLE | CCND3 MRE11 RBBP8 CSNK1D CSNK1E CHEK2 ATM GOLGA8O PLK4 GOLGA8N RAD50 | 1.33e-04 | 603 | 68 | 11 | MM14635 |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 1.40e-04 | 55 | 68 | 4 | M39598 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.61e-04 | 57 | 68 | 4 | MM15298 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 1.85e-04 | 59 | 68 | 4 | MM15283 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 1.85e-04 | 59 | 68 | 4 | M48104 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 1.86e-04 | 110 | 68 | 5 | M48043 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 3.57e-04 | 70 | 68 | 4 | M27570 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 4.65e-04 | 75 | 68 | 4 | MM15299 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 4.74e-04 | 7 | 68 | 2 | MM15989 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 4.74e-04 | 7 | 68 | 2 | MM15524 | |
| Pathway | WP_JOUBERT_SYNDROME | 4.89e-04 | 76 | 68 | 4 | M39835 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 5.40e-04 | 78 | 68 | 4 | M27589 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 6.25e-04 | 143 | 68 | 5 | MM15383 | |
| Pathway | BIOCARTA_PLK3_PATHWAY | 6.30e-04 | 8 | 68 | 2 | M22021 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 6.87e-04 | 146 | 68 | 5 | MM15292 | |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | 8.52e-04 | 88 | 68 | 4 | M1011 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 1.01e-03 | 10 | 68 | 2 | M47572 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 1.18e-03 | 96 | 68 | 4 | MM15207 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 1.22e-03 | 97 | 68 | 4 | M27590 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 1.22e-03 | 97 | 68 | 4 | M27478 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 1.25e-03 | 167 | 68 | 5 | M19381 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 1.36e-03 | 170 | 68 | 5 | M27582 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 1.50e-03 | 47 | 68 | 3 | MM15296 | |
| Pathway | PID_FANCONI_PATHWAY | 1.50e-03 | 47 | 68 | 3 | M1 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 1.59e-03 | 48 | 68 | 3 | M219 | |
| Pathway | KEGG_NON_HOMOLOGOUS_END_JOINING | 1.73e-03 | 13 | 68 | 2 | M7857 | |
| Pathway | KEGG_CIRCADIAN_RHYTHM_MAMMAL | 1.73e-03 | 13 | 68 | 2 | M18009 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 2.23e-03 | 54 | 68 | 3 | MM14904 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.31e-03 | 15 | 68 | 2 | M39442 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S | 2.31e-03 | 15 | 68 | 2 | M47524 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.31e-03 | 15 | 68 | 2 | MM15845 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 2.36e-03 | 116 | 68 | 4 | MM15294 | |
| Pathway | KEGG_OTHER_GLYCAN_DEGRADATION | 2.63e-03 | 16 | 68 | 2 | M17844 | |
| Pathway | REACTOME_MEIOSIS | 2.67e-03 | 120 | 68 | 4 | M529 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 2.98e-03 | 17 | 68 | 2 | M27788 | |
| Pathway | WP_WNT_SIGNALING | 3.16e-03 | 61 | 68 | 3 | MM15893 | |
| Pathway | BIOCARTA_MAL_PATHWAY | 3.34e-03 | 18 | 68 | 2 | MM1482 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 3.34e-03 | 18 | 68 | 2 | M31 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 3.41e-03 | 304 | 68 | 6 | MM14960 | |
| Pathway | REACTOME_PROTEIN_HYDROXYLATION | 3.72e-03 | 19 | 68 | 2 | MM17069 | |
| Pathway | BIOCARTA_MAL_PATHWAY | 3.72e-03 | 19 | 68 | 2 | M10547 | |
| Pathway | WP_P53_SIGNALING | 3.79e-03 | 65 | 68 | 3 | MM15852 | |
| Pubmed | 2.29e-10 | 5 | 92 | 4 | 16905549 | ||
| Pubmed | 6.85e-10 | 6 | 92 | 4 | 16357220 | ||
| Pubmed | Regulation of ceramide synthase-mediated crypt epithelium apoptosis by DNA damage repair enzymes. | 6.85e-10 | 6 | 92 | 4 | 20086180 | |
| Pubmed | ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. | 6.85e-10 | 6 | 92 | 4 | 15790808 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RIOX2 DHX36 MRE11 PTPN11 CS MDN1 SLC16A1 CSNK1E UCHL1 KIAA0586 SRP68 PRKCD ATM TTC3 ADAR DHX29 CLUH RPL10 DNMT1 RAD50 | 7.79e-10 | 1425 | 92 | 20 | 30948266 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RIOX2 DHX36 TICRR MDN1 AKAP17A UPF2 RBM27 PHF3 CSNK1E SRP68 ADAR DHX29 RPL10 DNMT1 WDR24 | 1.46e-09 | 759 | 92 | 15 | 35915203 |
| Pubmed | Pellino1 regulates reversible ATM activation via NBS1 ubiquitination at DNA double-strand breaks. | 1.59e-09 | 7 | 92 | 4 | 30952868 | |
| Pubmed | 53BP1 promotes ATM activity through direct interactions with the MRN complex. | 3.18e-09 | 8 | 92 | 4 | 20010693 | |
| Pubmed | Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype. | 3.18e-09 | 8 | 92 | 4 | 16540636 | |
| Pubmed | 1.49e-08 | 11 | 92 | 4 | 19584272 | ||
| Pubmed | Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. | 1.79e-08 | 3 | 92 | 3 | 19633668 | |
| Pubmed | Recruitment and activation of the ATM kinase in the absence of DNA-damage sensors. | 1.79e-08 | 3 | 92 | 3 | 26280532 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RPL10L YEATS2 SLF2 RBBP8 UCHL1 KIAA1217 ZNF451 ROCK1 ZDBF2 GIT2 RAD54L2 RAD50 | 5.18e-08 | 588 | 92 | 12 | 38580884 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RIOX2 MRE11 UPF2 RBM27 PHF3 MARF1 SRP68 GIT2 TTC3 ADAR DHX29 CDC42BPB CLUH | 6.12e-08 | 724 | 92 | 13 | 36232890 |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 18596698 | ||
| Pubmed | CDK targets Sae2 to control DNA-end resection and homologous recombination. | 7.15e-08 | 4 | 92 | 3 | 18716619 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 20192920 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 28369484 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 27889449 | ||
| Pubmed | The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. | 7.15e-08 | 4 | 92 | 3 | 17429352 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 28855246 | ||
| Pubmed | Disease-associated MRE11 mutants impact ATM/ATR DNA damage signaling by distinct mechanisms. | 7.15e-08 | 4 | 92 | 3 | 23912341 | |
| Pubmed | Independent roles for nibrin and Mre11-Rad50 in the activation and function of Atm. | 7.15e-08 | 4 | 92 | 3 | 15234984 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 27814491 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 18256278 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 21150274 | ||
| Pubmed | Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. | 7.15e-08 | 4 | 92 | 3 | 15965469 | |
| Pubmed | 1.43e-07 | 222 | 92 | 8 | 37071664 | ||
| Pubmed | 1.49e-07 | 149 | 92 | 7 | 25184681 | ||
| Pubmed | DHX36 MRE11 MDN1 PHF3 ATAD2B OASL SRP68 ATM CLUH RPL10 DNMT1 RAD50 | 1.60e-07 | 653 | 92 | 12 | 22586326 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 24220101 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 18710941 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 18829552 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 23525106 | ||
| Pubmed | Destabilization of linker histone H1.2 is essential for ATM activation and DNA damage repair. | 1.78e-07 | 5 | 92 | 3 | 29844578 | |
| Pubmed | Analysis of variants in DNA damage signalling genes in bladder cancer. | 1.78e-07 | 5 | 92 | 3 | 18638378 | |
| Pubmed | ATM activation is impaired in human cells defective in RecQL4 helicase activity. | 1.78e-07 | 5 | 92 | 3 | 30594395 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 24534091 | ||
| Pubmed | RIOX2 MRPS30 MRE11 C3P1 SNX4 PTPN11 MDN1 PHF3 ZNF451 ROCK1 CLUH RPL10 | 2.84e-07 | 689 | 92 | 12 | 36543142 | |
| Pubmed | 3.54e-07 | 453 | 92 | 10 | 29656893 | ||
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 18381424 | ||
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 30657944 | ||
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 18171670 | ||
| Pubmed | MDC1 is required for the intra-S-phase DNA damage checkpoint. | 3.56e-07 | 6 | 92 | 3 | 12607003 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 29709199 | ||
| Pubmed | Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. | 3.56e-07 | 6 | 92 | 3 | 15064416 | |
| Pubmed | ATM-mediated KDM2A phosphorylation is required for the DNA damage repair. | 3.56e-07 | 6 | 92 | 3 | 25823024 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 30733337 | ||
| Pubmed | NBS1 prevents chromatid-type aberrations through ATM-dependent interactions with SMC1. | 3.56e-07 | 6 | 92 | 3 | 18763866 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PLEKHG1 CRTC3 MDN1 KCNQ5 SLC16A1 SLF2 CSNK1D PHF3 CSNK1E KIAA1217 PLK4 DNMT1 MAP3K2 | 4.42e-07 | 861 | 92 | 13 | 36931259 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | RIOX2 MRE11 TICRR MDN1 ANK1 HSPBAP1 ATAD2B PCIF1 SRP68 ATM ZZEF1 RPL10 | 5.71e-07 | 736 | 92 | 12 | 29676528 |
| Pubmed | The ATM signaling cascade promotes recombination-dependent pachytene arrest in mouse spermatocytes. | 6.22e-07 | 7 | 92 | 3 | 25768017 | |
| Pubmed | MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. | 6.22e-07 | 7 | 92 | 3 | 19221393 | |
| Pubmed | Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1. | 6.22e-07 | 7 | 92 | 3 | 22464731 | |
| Pubmed | MRE11-RAD50-NBS1 and ATM function as co-mediators of TRF1 in telomere length control. | 6.22e-07 | 7 | 92 | 3 | 17694070 | |
| Pubmed | 6.22e-07 | 7 | 92 | 3 | 36563124 | ||
| Pubmed | Mre11 regulates CtIP-dependent double-strand break repair by interaction with CDK2. | 6.22e-07 | 7 | 92 | 3 | 22231403 | |
| Pubmed | Inhibition of hsp90 compromises the DNA damage response to radiation. | 6.22e-07 | 7 | 92 | 3 | 16982765 | |
| Pubmed | Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage. | 6.22e-07 | 7 | 92 | 3 | 18614044 | |
| Pubmed | 6.22e-07 | 7 | 92 | 3 | 14519663 | ||
| Pubmed | Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. | 7.17e-07 | 117 | 92 | 6 | 19124506 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | YEATS2 MRE11 MDN1 RBBP8 PHF3 CSNK1E PRKCD ATM DHX29 CLUH DNMT1 RAD50 | 9.67e-07 | 774 | 92 | 12 | 15302935 |
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 15456891 | ||
| Pubmed | USP4 Auto-Deubiquitylation Promotes Homologous Recombination. | 9.94e-07 | 8 | 92 | 3 | 26455393 | |
| Pubmed | CSB interacts with BRCA1 in late S/G2 to promote MRN- and CtIP-mediated DNA end resection. | 9.94e-07 | 8 | 92 | 3 | 31501894 | |
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 19638463 | ||
| Pubmed | Role of the translocation partner in protection against AID-dependent chromosomal translocations. | 9.94e-07 | 8 | 92 | 3 | 19966290 | |
| Pubmed | ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. | 9.94e-07 | 8 | 92 | 3 | 15916964 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX36 MRE11 UPF2 SLC16A1 RBM27 CSNK1D PHF3 CSNK1E KIAA1217 OASL SRP68 ADAR RPL10 DNMT1 RAD50 | 1.04e-06 | 1257 | 92 | 15 | 36526897 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RASSF5 YEATS2 MRE11 PTPN11 RBM27 UCHL1 KIAA1217 SRP68 ADAR DHX29 RPL10 DNMT1 RAD50 | 1.10e-06 | 934 | 92 | 13 | 33916271 |
| Pubmed | 1.37e-06 | 31 | 92 | 4 | 19690177 | ||
| Pubmed | 1.77e-06 | 33 | 92 | 4 | 19714462 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX36 YEATS2 MRE11 CS MDN1 ANK1 AKAP17A UPF2 SLC16A1 RBM27 SRP68 ADAR CDKAL1 RPL10 DNMT1 | 1.87e-06 | 1318 | 92 | 15 | 30463901 |
| Pubmed | YEATS2 MRE11 PTPN11 SLC16A1 RBM27 PHF3 SRP68 ADAR DNMT1 RAD50 | 2.00e-06 | 549 | 92 | 10 | 38280479 | |
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 29523790 | ||
| Pubmed | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. | 2.91e-06 | 11 | 92 | 3 | 15758953 | |
| Pubmed | 2.91e-06 | 11 | 92 | 3 | 12607005 | ||
| Pubmed | SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. | 2.91e-06 | 11 | 92 | 3 | 11877377 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.94e-06 | 332 | 92 | 8 | 32786267 | |
| Pubmed | MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining. | 3.87e-06 | 12 | 92 | 3 | 30017584 | |
| Pubmed | Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. | 3.87e-06 | 12 | 92 | 3 | 16391231 | |
| Pubmed | 3.87e-06 | 12 | 92 | 3 | 15149599 | ||
| Pubmed | 3.87e-06 | 12 | 92 | 3 | 10783165 | ||
| Pubmed | 4.04e-06 | 89 | 92 | 5 | 18950845 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 22369660 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 16600870 | ||
| Pubmed | RAD50 regulates mitotic progression independent of DNA repair functions. | 6.92e-06 | 2 | 92 | 2 | 31908056 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 33607997 | ||
| Pubmed | Poly-ADP-ribosylation drives loss of protein homeostasis in ATM and Mre11 deficiency. | 6.92e-06 | 2 | 92 | 2 | 33571423 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12857758 | ||
| Pubmed | Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange. | 6.92e-06 | 2 | 92 | 2 | 16794575 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 25659036 | ||
| Pubmed | Decreased expression of MRE11 and RAD50 in testes from humans with spermatogenic failure. | 6.92e-06 | 2 | 92 | 2 | 31983050 | |
| Pubmed | Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression. | 6.92e-06 | 2 | 92 | 2 | 25872745 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24424021 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23220400 | ||
| Pubmed | Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers. | 6.92e-06 | 2 | 92 | 2 | 33919281 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9632646 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20599567 | ||
| Pubmed | ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining. | 6.92e-06 | 2 | 92 | 2 | 20647759 | |
| Interaction | PER3 interactions | 7.05e-08 | 24 | 92 | 5 | int:PER3 | |
| Interaction | WWTR1 interactions | YEATS2 MRE11 PTPN11 RBM27 PHF3 UCHL1 SRP68 ADAR DNMT1 MAP3K2 RAD50 | 3.50e-06 | 422 | 92 | 11 | int:WWTR1 |
| Interaction | HECTD1 interactions | RIOX2 DHX36 TICRR MDN1 AKAP17A UPF2 RBM27 PHF3 CSNK1E DNM3 SRP68 ADAR DHX29 RPL10 DNMT1 WDR24 | 8.84e-06 | 984 | 92 | 16 | int:HECTD1 |
| Interaction | CACNG2 interactions | 1.50e-05 | 33 | 92 | 4 | int:CACNG2 | |
| Interaction | BIRC3 interactions | RIOX2 DHX36 MRE11 CS MDN1 SLC16A1 CSNK1E UCHL1 KIAA0586 SRP68 PRKCD TTC3 ADAR DHX29 CLUH RPL10 DNMT1 RAD50 | 2.86e-05 | 1334 | 92 | 18 | int:BIRC3 |
| Interaction | PYHIN1 interactions | 3.78e-05 | 358 | 92 | 9 | int:PYHIN1 | |
| Interaction | DCLRE1C interactions | 4.38e-05 | 43 | 92 | 4 | int:DCLRE1C | |
| Interaction | SLX4 interactions | YEATS2 MRE11 PTPN11 MDN1 SLF2 CSNK1E ZNF451 RAD54L2 ADAR RPL10 RAD50 | 5.88e-05 | 572 | 92 | 11 | int:SLX4 |
| Interaction | CCT8L2 interactions | 8.34e-05 | 157 | 92 | 6 | int:CCT8L2 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.29e-07 | 5 | 59 | 3 | 1336 | |
| GeneFamily | BRCA1 C complex|MRN complex | 3.13e-05 | 3 | 59 | 2 | 1344 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.89e-04 | 8 | 59 | 2 | 281 | |
| GeneFamily | DEAH-box helicases | 1.22e-03 | 16 | 59 | 2 | 500 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.76e-03 | 24 | 59 | 2 | 654 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 1.54e-06 | 230 | 92 | 8 | M11563 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | MRPS30 DHX36 MRE11 PTPN11 SLC16A1 RBBP8 CSNK1D OGFOD1 TTC3 PLK4 DNMT1 RAD50 | 8.32e-06 | 721 | 92 | 12 | M10237 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CCND3 RIOX2 PTPN11 MDN1 AKAP17A UPF2 SLF2 CSNK1D AGA ATAD2B PRKCD ROCK1 ATM TTC3 PLK4 | 2.06e-05 | 1215 | 92 | 15 | M41122 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | PMS2P2 MRE11 SNX4 AKAP17A UPF2 RBBP8 KCNH1 PHF3 CHEK2 PRKCD ROCK1 GIT2 ATM ADAR PLK4 DNMT1 | 2.57e-05 | 1394 | 92 | 16 | M9585 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 2.87e-05 | 168 | 92 | 6 | M18811 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 2.90e-05 | 101 | 92 | 5 | M15356 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 6.11e-05 | 118 | 92 | 5 | M15305 | |
| Coexpression | GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN | 6.96e-05 | 197 | 92 | 6 | M3255 | |
| Coexpression | GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 7.16e-05 | 198 | 92 | 6 | M4247 | |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN | 7.36e-05 | 199 | 92 | 6 | M4310 | |
| Coexpression | GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN | 7.57e-05 | 200 | 92 | 6 | M7801 | |
| Coexpression | GSE17721_CTRL_VS_CPG_2H_BMDC_UP | 7.57e-05 | 200 | 92 | 6 | M3759 | |
| Coexpression | EPPERT_PROGENITOR | 1.28e-04 | 138 | 92 | 5 | M19232 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 1.29e-04 | 426 | 92 | 8 | M9516 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | RBM27 CSNK1D PHF3 CSNK1E ZNF451 PCIF1 MARF1 ZDBF2 JMY MAP3K2 | 1.38e-04 | 680 | 92 | 10 | M41089 |
| Coexpression | JAIN_NFKB_SIGNALING | 1.43e-04 | 75 | 92 | 4 | M17646 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MOK DHX36 TICRR MDN1 UPF2 SLC16A1 RBM27 RBBP8 PHF3 ATAD2B KIAA0586 CFAP74 ROCK1 ZDBF2 ATM KIF24 PLK4 CDKAL1 DNMT1 RAD50 | 1.27e-07 | 1257 | 87 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MOK DHX36 TICRR MDN1 KCNQ5 UPF2 SLC16A1 RBM27 RBBP8 PHF3 ATAD2B KIAA0586 CFAP74 ROCK1 ZDBF2 ATM KIF24 PLK4 CDKAL1 DNMT1 RAD50 | 3.08e-07 | 1459 | 87 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.13e-06 | 258 | 87 | 9 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.45e-06 | 266 | 87 | 9 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RIOX2 RPL10L MRE11 TICRR MDN1 SLC16A1 RBM27 UCHL1 ZNF451 KIAA0586 CHEK2 ATM EPB41L4A RAD50 | 4.30e-06 | 799 | 87 | 14 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | RBM27 RBBP8 PHF3 ROCK1 ZDBF2 ATM EPB41L4A TTC3 KIF24 PLK4 DNMT1 | 1.10e-05 | 532 | 87 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SNX4 PTPN11 UPF2 SLF2 CSNK1D ATAD2B KIAA0586 CHEK2 CFAP74 DHX29 RAD50 | 1.90e-05 | 564 | 87 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.33e-05 | 243 | 87 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RIOX2 RPL10L MRE11 TICRR MDN1 SLC16A1 RBM27 ZNF451 CHEK2 ATM EPB41L4A RAD50 | 7.95e-05 | 781 | 87 | 12 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | RIOX2 MRE11 TICRR MDN1 RBM27 UCHL1 ZNF451 CHEK2 ATM EPB41L4A PLK4 RAD50 | 9.41e-05 | 795 | 87 | 12 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | RIOX2 MDN1 RBM27 HSPBAP1 UCHL1 ZNF451 KIAA0586 CHEK2 ATM EPB41L4A KIF24 RAD50 | 1.12e-04 | 810 | 87 | 12 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | RIOX2 MRE11 TICRR MDN1 RBM27 RBBP8 ZNF451 CHEK2 ATM EPB41L4A KIF24 RAD50 | 1.26e-04 | 820 | 87 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | RIOX2 MRE11 TICRR MDN1 RBM27 UCHL1 ZNF451 KIAA0586 CHEK2 ATM EPB41L4A RAD50 | 1.29e-04 | 822 | 87 | 12 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.72e-06 | 177 | 91 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.67e-06 | 191 | 91 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.67e-06 | 191 | 91 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.39e-06 | 199 | 91 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-06 | 200 | 91 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.38e-05 | 167 | 91 | 5 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.67e-05 | 171 | 91 | 5 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 178 | 91 | 5 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 178 | 91 | 5 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 179 | 91 | 5 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.50e-05 | 181 | 91 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.60e-05 | 182 | 91 | 5 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 186 | 91 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 186 | 91 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 186 | 91 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.64e-05 | 192 | 91 | 5 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.87e-05 | 194 | 91 | 5 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 194 | 91 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.12e-05 | 196 | 91 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 5.12e-05 | 196 | 91 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 5.12e-05 | 196 | 91 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 5.24e-05 | 197 | 91 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.24e-05 | 197 | 91 | 5 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 5.24e-05 | 197 | 91 | 5 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 5.50e-05 | 199 | 91 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.50e-05 | 199 | 91 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.50e-05 | 199 | 91 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.25e-06 | 197 | 91 | 8 | 3399_DN | |
| Drug | Verdict | 5.25e-06 | 29 | 91 | 4 | CID000050896 | |
| Drug | wortmannin | 1.18e-05 | 267 | 91 | 8 | ctd:C009687 | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 91 | 7 | 5393_UP | |
| Drug | methyl methanesulfonate | 1.53e-05 | 364 | 91 | 9 | CID000004156 | |
| Drug | ethyl acetate | 1.86e-05 | 137 | 91 | 6 | CID000008857 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 2.45e-09 | 7 | 87 | 4 | DOID:0060807 (implicated_via_orthology) | |
| Disease | Breast Cancer, Familial | 1.82e-06 | 30 | 87 | 4 | C0346153 | |
| Disease | Nijmegen Breakage Syndrome-Like Disorder | 8.59e-06 | 2 | 87 | 2 | C2751318 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 8.80e-06 | 14 | 87 | 3 | C0677776 | |
| Disease | T-cell acute lymphoblastic leukemia (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:5603 (implicated_via_orthology) | |
| Disease | unipolar depression, neuroticism measurement | 4.79e-05 | 24 | 87 | 3 | EFO_0003761, EFO_0007660 | |
| Disease | autistic disorder (implicated_via_orthology) | 5.14e-05 | 4 | 87 | 2 | DOID:12849 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MRE11 MAN2C1 ANK1 ZNF366 KCNH1 CSNK1D CHEK2 CTIF ATM TTC3 ADAR DNMT1 | 7.30e-05 | 1074 | 87 | 12 | C0006142 |
| Disease | sporadic Creutzfeld Jacob disease | 8.54e-05 | 5 | 87 | 2 | EFO_1000656 | |
| Disease | serum metabolite measurement | CCND3 ACADL AGA OASL PCIF1 PRKCD ABCC2 GRM7 MAP4K2 CDKAL1 DNMT1 | 1.04e-04 | 945 | 87 | 11 | EFO_0005653 |
| Disease | mean arterial pressure | 1.15e-04 | 499 | 87 | 8 | EFO_0006340 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 1.28e-04 | 6 | 87 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | insulin sensitivity measurement, insulin response measurement | 2.38e-04 | 8 | 87 | 2 | EFO_0004471, EFO_0008473 | |
| Disease | female breast cancer (is_implicated_in) | 2.38e-04 | 8 | 87 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | insulin response measurement | 3.05e-04 | 9 | 87 | 2 | EFO_0008473 | |
| Disease | Neuroblastoma | 3.65e-04 | 47 | 87 | 3 | C0027819 | |
| Disease | obsolete_red blood cell distribution width | CCND3 MOK PLEKHG1 STAC2 ANK1 RBM27 ZNF366 KIAA1217 ATAD2B PCIF1 CHEK2 CLUH | 5.83e-04 | 1347 | 87 | 12 | EFO_0005192 |
| Disease | mean reticulocyte volume | 5.83e-04 | 799 | 87 | 9 | EFO_0010701 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 6.56e-04 | 13 | 87 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 9.30e-04 | 525 | 87 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 9.30e-04 | 525 | 87 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 9.50e-04 | 527 | 87 | 7 | C1458155 | |
| Disease | Breast Carcinoma | 1.07e-03 | 538 | 87 | 7 | C0678222 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 1.42e-03 | 19 | 87 | 2 | C1333991 | |
| Disease | leukemia (implicated_via_orthology) | 1.42e-03 | 19 | 87 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 1.42e-03 | 19 | 87 | 2 | C2936783 | |
| Disease | Adenocarcinoma of prostate | 1.58e-03 | 20 | 87 | 2 | C0007112 | |
| Disease | feeling miserable measurement | 1.67e-03 | 79 | 87 | 3 | EFO_0009598 | |
| Disease | Seckel syndrome | 1.91e-03 | 22 | 87 | 2 | C0265202 | |
| Disease | Attention Deficit Disorder | 1.91e-03 | 22 | 87 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.91e-03 | 22 | 87 | 2 | C1321905 | |
| Disease | Primary microcephaly | 1.91e-03 | 22 | 87 | 2 | C0431350 | |
| Disease | Attention deficit hyperactivity disorder | 2.27e-03 | 24 | 87 | 2 | C1263846 | |
| Disease | neutrophil count | CCND3 RASSF5 STAC2 TADA1 ZNF366 RBBP8 CHEK2 DNM3 ADAR CDKAL1 DNMT1 | 2.44e-03 | 1382 | 87 | 11 | EFO_0004833 |
| Disease | myeloproliferative disorder | 2.47e-03 | 25 | 87 | 2 | EFO_0004251 | |
| Disease | breast cancer (implicated_via_orthology) | 2.47e-03 | 25 | 87 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | birth weight, parental genotype effect measurement | 2.54e-03 | 192 | 87 | 4 | EFO_0004344, EFO_0005939 | |
| Disease | Neurodevelopmental Disorders | 2.65e-03 | 93 | 87 | 3 | C1535926 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.67e-03 | 26 | 87 | 2 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.88e-03 | 27 | 87 | 2 | C1112155 | |
| Disease | Malignant tumor of breast | 2.88e-03 | 27 | 87 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 2.88e-03 | 27 | 87 | 2 | cv:C1458155 | |
| Disease | Familial cancer of breast | 2.88e-03 | 27 | 87 | 2 | cv:C0346153 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRDRQALVKKHAQTF | 171 | P30281 | |
| QPEKLDFTQFHRKVR | 116 | O43310 | |
| DFTQFHRKVRHTPKQ | 121 | O43310 | |
| QNFPHIEVVRKKEER | 791 | Q99708 | |
| IRVNKFYRPENTHKS | 1016 | P26358 | |
| RKSVRKFFQEEVIPH | 61 | P28330 | |
| LVPVKKAAQQRSFHF | 1301 | P16157 | |
| QDKVHPNKAEFIRAK | 96 | Q14161 | |
| NKPEEVQPRFFKVHI | 361 | Q9Y4B4 | |
| KKHFRIFREVGPKNS | 141 | O96017 | |
| LKERQQLPVFKHRDS | 566 | Q7Z478 | |
| DPNRNVEHRERSKFK | 191 | Q9P2N5 | |
| VVDNPQKFALFKRIH | 311 | Q8WWW0 | |
| GPFSERQIKNFHKLV | 386 | Q92878 | |
| IHFKKELREPQFRDA | 1086 | Q92878 | |
| QFHQVKFGAPRRKET | 331 | Q12851 | |
| RHPKQEKRSVFQTIN | 236 | P53985 | |
| INHRSLEQKKTFPNR | 516 | Q8N543 | |
| EREFRKQFPLHEKDF | 3571 | Q9NU22 | |
| VRPHVFDEREKHKFV | 16 | Q8N9B5 | |
| QKERFNIDMPHRFKV | 221 | Q05655 | |
| VPAHQKKRENTLFDI | 301 | Q9ULI0 | |
| REFLFNLPDQKARKH | 566 | Q9ULI0 | |
| KHFEKRRNPAANLIQ | 361 | Q9NR82 | |
| IHRFVEKPQVFVSNK | 156 | Q9Y5P6 | |
| KINRIFHERFPFEIV | 361 | Q9UQ16 | |
| SKNFIHRDVKPDNFL | 121 | P48730 | |
| HEKLRQLAKPQSVFE | 361 | H3BV12 | |
| VKFEHRGEKRILQFP | 46 | Q9Y2U5 | |
| FRQLEVSQPRKHLFV | 341 | Q5T7B8 | |
| LNRKVFKEHPAFRLA | 571 | O95259 | |
| PVIRAFEHQQRFLKH | 1171 | Q92887 | |
| QHPYFQEQRKTEKRA | 281 | Q9UQ07 | |
| KNRYKNILPFDHTRV | 276 | Q06124 | |
| EIQRTKPFHRKFNEI | 1356 | Q9Y5S2 | |
| IIFHPEQNVQKRKRS | 841 | O00222 | |
| FSELQRNFVKHRPTK | 191 | Q15646 | |
| ECQPRRNIVFLKTHK | 71 | Q99999 | |
| DLKRFPQFRKAQRHA | 226 | Q96EW2 | |
| PDHVVFKDLRITQQK | 1566 | Q13315 | |
| AKLFFRRRHQQKDPG | 631 | Q9Y426 | |
| QSRFKRHQLILPAFE | 601 | Q9H4Z3 | |
| HEPRFKFQVVINGRE | 531 | P55265 | |
| RQAKVRVEFPHKETL | 96 | Q6ZMU1 | |
| DSKPQDRHFVRKDVV | 21 | Q5VV42 | |
| NPRKFSEKIALHTQR | 11 | Q6UUV7 | |
| RYVPEQKEHRSQFKR | 406 | Q9H2U1 | |
| IPKEQARIKTFRQQH | 41 | O75390 | |
| QKNLPDFRIHKITQR | 26 | Q5I0G3 | |
| KQFSKDVVDLLRHQP | 1261 | Q9Y4F3 | |
| EAHKFLKVEFPARVR | 806 | Q9NTJ4 | |
| FRNLADKHVRPIQFV | 421 | P10911 | |
| CQKVISRIQKHFPEF | 286 | P20933 | |
| HPELNVQKRKRSFKA | 851 | Q14831 | |
| HEKLRQLAKPQSVFE | 361 | A6NCC3 | |
| RITKVHFKETQFELR | 246 | Q9HCS5 | |
| AQNRDKLFKVSVPHV | 1151 | Q9C0B2 | |
| REDAPHFLKEQQRKS | 176 | Q56UN5 | |
| GDFRFHVRKKDQINI | 646 | Q9HAU5 | |
| EHVIEALRRAKFKFP | 146 | Q96L21 | |
| IVHFLLNRPKEEKSQ | 421 | Q9NP92 | |
| FRVKNPDKRFTDLKH | 211 | O95219 | |
| KLSSVRQKFDHRFQP | 101 | Q96BN2 | |
| EHVIEALRRAKFKFP | 146 | P27635 | |
| NQEPFKVRLHLAKDI | 21 | Q9NSN8 | |
| KQLFSTLPVRHKEFQ | 21 | O95744 | |
| QHKEAKRFEIARSQP | 1616 | Q5T5P2 | |
| PERRKSLFIHENNEK | 171 | Q8IX21 | |
| NPKDIIHFFRHREQK | 391 | P49959 | |
| LKNRVKPFSENEARH | 101 | O00444 | |
| LKQEANTEPRKRFHL | 141 | Q9UHB9 | |
| ASKHKQEIRKNPEFR | 51 | Q96H20 | |
| KVRAAEFKIDFPTRH | 111 | Q02040 | |
| NFAVLQKKRVQRHPF | 296 | O75153 | |
| ELENQFKKTQRPAHI | 986 | Q9Y4E5 | |
| FPRIFDLITHQKKQC | 2276 | Q86UP3 | |
| QRHFQKPVRIFLKGS | 331 | Q7Z2Z1 | |
| KPVRLHSFQEHVFKR | 106 | Q6ZMT1 | |
| HARELPKKRNFQLTF | 2136 | Q9HCK1 | |
| PKKRNFQLTFLNHDV | 2141 | Q9HCK1 | |
| LNFVEKERDFRKINH | 386 | P53804 | |
| ESQQNFHRPVKVRKK | 536 | Q92576 | |
| KDFDQKRATIQFHQP | 126 | Q8IUF8 | |
| KRATIQFHQPQRFKD | 131 | Q8IUF8 | |
| RNGVEEIKRHLFFKN | 326 | Q13464 | |
| NEQFINAAKIIRHPK | 141 | P35030 | |
| FDLSQKRRAKVPVFQ | 591 | Q8N895 | |
| HEEIRPVDFKQRNKA | 2011 | O43149 | |
| KFFRERQETLKHSLP | 226 | Q9ULL1 | |
| RPSRNKQDQLFTEHK | 106 | Q96S15 | |
| KRHDLTRLNPKVQDF | 181 | Q63HR2 | |
| IPRKHSQKQIEEHFR | 581 | Q9BVV6 | |
| PVRVQVHFKDSQNKR | 286 | Q9ULM3 | |
| LLFPLTAQHENFRKK | 51 | P09936 | |
| HEKLRQLAKPQSVFE | 361 | F8WBI6 | |
| SKNFIHRDVKPDNFL | 121 | P49674 | |
| RKEPSKFDDFLIRHQ | 601 | Q8N1T3 |